Does the media refer more to EW or HSIC?

In the previous week, Edwards Lifesciences had 19 more articles in the media than Henry Schein. MarketBeat recorded 22 mentions for Edwards Lifesciences and 3 mentions for Henry Schein. Edwards Lifesciences' average media sentiment score of 1.22 beat Henry Schein's score of 1.10 indicating that Edwards Lifesciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Edwards Lifesciences 15 Very Positive mention(s) 3 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Henry Schein 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer AMN or EW?

In the previous week, Edwards Lifesciences had 9 more articles in the media than AMN Healthcare Services. MarketBeat recorded 22 mentions for Edwards Lifesciences and 13 mentions for AMN Healthcare Services. Edwards Lifesciences' average media sentiment score of 1.22 beat AMN Healthcare Services' score of 0.42 indicating that Edwards Lifesciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment AMN Healthcare Services 3 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Edwards Lifesciences 15 Very Positive mention(s) 3 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to EW or ABT?

In the previous week, Abbott Laboratories had 29 more articles in the media than Edwards Lifesciences. MarketBeat recorded 51 mentions for Abbott Laboratories and 22 mentions for Edwards Lifesciences. Abbott Laboratories' average media sentiment score of 1.53 beat Edwards Lifesciences' score of 1.22 indicating that Abbott Laboratories is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Edwards Lifesciences 15 Very Positive mention(s) 3 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Abbott Laboratories 46 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Does the media prefer ISRG or EW?

In the previous week, Intuitive Surgical had 43 more articles in the media than Edwards Lifesciences. MarketBeat recorded 65 mentions for Intuitive Surgical and 22 mentions for Edwards Lifesciences. Intuitive Surgical's average media sentiment score of 1.51 beat Edwards Lifesciences' score of 1.22 indicating that Intuitive Surgical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Intuitive Surgical 60 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Very Positive Edwards Lifesciences 15 Very Positive mention(s) 3 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor EW or SYK?

In the previous week, Stryker had 13 more articles in the media than Edwards Lifesciences. MarketBeat recorded 35 mentions for Stryker and 22 mentions for Edwards Lifesciences. Stryker's average media sentiment score of 1.50 beat Edwards Lifesciences' score of 1.22 indicating that Stryker is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Edwards Lifesciences 15 Very Positive mention(s) 3 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Stryker 32 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Very Positive

Edwards Lifesciences (EW) Competitors

$87.51 +0.15 (+0.17%)

Closing price 06/18/2026 03:59 PM Eastern

Extended Trading

$86.97 -0.53 (-0.61%)

As of 06/18/2026 07:56 PM Eastern

Compare

EW vs. HSIC, AMN, ABT, ISRG, and SYK

Should you buy Edwards Lifesciences stock or one of its competitors? MarketBeat compares Edwards Lifesciences with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Edwards Lifesciences include Henry Schein (HSIC), AMN Healthcare Services (AMN), Abbott Laboratories (ABT), Intuitive Surgical (ISRG), and Stryker (SYK). These companies are all part of the "medical" sector.

How does Edwards Lifesciences compare to Henry Schein?

Edwards Lifesciences (NYSE:EW) and Henry Schein (NASDAQ:HSIC) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, earnings, media sentiment, valuation, analyst recommendations, risk, dividends and profitability.

Edwards Lifesciences has a beta of 0.87, suggesting that its share price is 13% less volatile than the broader market. Comparatively, Henry Schein has a beta of 0.82, suggesting that its share price is 18% less volatile than the broader market.

Edwards Lifesciences has higher earnings, but lower revenue than Henry Schein. Henry Schein is trading at a lower price-to-earnings ratio than Edwards Lifesciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Edwards Lifesciences	$6.07B	8.30	$1.07B	$1.88	46.55
Henry Schein	$13.18B	0.69	$398M	$3.31	24.15

In the previous week, Edwards Lifesciences had 19 more articles in the media than Henry Schein. MarketBeat recorded 22 mentions for Edwards Lifesciences and 3 mentions for Henry Schein. Edwards Lifesciences' average media sentiment score of 1.22 beat Henry Schein's score of 1.10 indicating that Edwards Lifesciences is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Edwards Lifesciences	15 Very Positive mention(s)	3 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Henry Schein	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Edwards Lifesciences has a net margin of 17.39% compared to Henry Schein's net margin of 2.95%. Henry Schein's return on equity of 15.44% beat Edwards Lifesciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Edwards Lifesciences	17.39%	15.19%	11.71%
Henry Schein	2.95%	15.44%	5.53%

Edwards Lifesciences currently has a consensus price target of $95.96, suggesting a potential upside of 9.66%. Henry Schein has a consensus price target of $87.85, suggesting a potential upside of 9.92%. Given Henry Schein's higher possible upside, analysts plainly believe Henry Schein is more favorable than Edwards Lifesciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Edwards Lifesciences	0 Sell rating(s)	8 Hold rating(s)	16 Buy rating(s)	3 Strong Buy rating(s)	2.81
Henry Schein	1 Sell rating(s)	6 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.43

79.5% of Edwards Lifesciences shares are owned by institutional investors. Comparatively, 96.6% of Henry Schein shares are owned by institutional investors. 0.3% of Edwards Lifesciences shares are owned by company insiders. Comparatively, 0.9% of Henry Schein shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

Edwards Lifesciences beats Henry Schein on 11 of the 17 factors compared between the two stocks.

How does Edwards Lifesciences compare to AMN Healthcare Services?

AMN Healthcare Services (NYSE:AMN) and Edwards Lifesciences (NYSE:EW) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, institutional ownership, valuation, analyst recommendations, media sentiment, risk, earnings and profitability.

Edwards Lifesciences has higher revenue and earnings than AMN Healthcare Services. AMN Healthcare Services is trading at a lower price-to-earnings ratio than Edwards Lifesciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AMN Healthcare Services	$2.73B	0.44	-$95.70M	-$0.87	N/A
Edwards Lifesciences	$6.07B	8.30	$1.07B	$1.88	46.55

In the previous week, Edwards Lifesciences had 9 more articles in the media than AMN Healthcare Services. MarketBeat recorded 22 mentions for Edwards Lifesciences and 13 mentions for AMN Healthcare Services. Edwards Lifesciences' average media sentiment score of 1.22 beat AMN Healthcare Services' score of 0.42 indicating that Edwards Lifesciences is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
AMN Healthcare Services	3 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Edwards Lifesciences	15 Very Positive mention(s)	3 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Edwards Lifesciences has a net margin of 17.39% compared to AMN Healthcare Services' net margin of -0.95%. AMN Healthcare Services' return on equity of 18.01% beat Edwards Lifesciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AMN Healthcare Services	-0.95%	18.01%	5.19%
Edwards Lifesciences	17.39%	15.19%	11.71%

99.2% of AMN Healthcare Services shares are owned by institutional investors. Comparatively, 79.5% of Edwards Lifesciences shares are owned by institutional investors. 1.1% of AMN Healthcare Services shares are owned by insiders. Comparatively, 0.3% of Edwards Lifesciences shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

AMN Healthcare Services has a beta of 0.44, meaning that its stock price is 56% less volatile than the broader market. Comparatively, Edwards Lifesciences has a beta of 0.87, meaning that its stock price is 13% less volatile than the broader market.

AMN Healthcare Services presently has a consensus target price of $25.29, suggesting a potential downside of 18.47%. Edwards Lifesciences has a consensus target price of $95.96, suggesting a potential upside of 9.66%. Given Edwards Lifesciences' stronger consensus rating and higher probable upside, analysts clearly believe Edwards Lifesciences is more favorable than AMN Healthcare Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AMN Healthcare Services	2 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.22
Edwards Lifesciences	0 Sell rating(s)	8 Hold rating(s)	16 Buy rating(s)	3 Strong Buy rating(s)	2.81

Summary

Edwards Lifesciences beats AMN Healthcare Services on 14 of the 17 factors compared between the two stocks.

How does Edwards Lifesciences compare to Abbott Laboratories?

Edwards Lifesciences (NYSE:EW) and Abbott Laboratories (NYSE:ABT) are both large-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, media sentiment, risk, valuation, dividends, analyst recommendations, earnings and institutional ownership.

Abbott Laboratories has higher revenue and earnings than Edwards Lifesciences. Abbott Laboratories is trading at a lower price-to-earnings ratio than Edwards Lifesciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Edwards Lifesciences	$6.07B	8.30	$1.07B	$1.88	46.55
Abbott Laboratories	$44.33B	3.48	$6.52B	$3.57	24.78

Edwards Lifesciences has a net margin of 17.39% compared to Abbott Laboratories' net margin of 13.90%. Abbott Laboratories' return on equity of 17.62% beat Edwards Lifesciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Edwards Lifesciences	17.39%	15.19%	11.71%
Abbott Laboratories	13.90%	17.62%	10.01%

Edwards Lifesciences currently has a consensus target price of $95.96, indicating a potential upside of 9.66%. Abbott Laboratories has a consensus target price of $118.30, indicating a potential upside of 33.71%. Given Abbott Laboratories' stronger consensus rating and higher probable upside, analysts plainly believe Abbott Laboratories is more favorable than Edwards Lifesciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Edwards Lifesciences	0 Sell rating(s)	8 Hold rating(s)	16 Buy rating(s)	3 Strong Buy rating(s)	2.81
Abbott Laboratories	1 Sell rating(s)	4 Hold rating(s)	19 Buy rating(s)	2 Strong Buy rating(s)	2.85

79.5% of Edwards Lifesciences shares are held by institutional investors. Comparatively, 75.2% of Abbott Laboratories shares are held by institutional investors. 0.3% of Edwards Lifesciences shares are held by insiders. Comparatively, 0.5% of Abbott Laboratories shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Edwards Lifesciences has a beta of 0.87, suggesting that its stock price is 13% less volatile than the broader market. Comparatively, Abbott Laboratories has a beta of 0.63, suggesting that its stock price is 37% less volatile than the broader market.

In the previous week, Abbott Laboratories had 29 more articles in the media than Edwards Lifesciences. MarketBeat recorded 51 mentions for Abbott Laboratories and 22 mentions for Edwards Lifesciences. Abbott Laboratories' average media sentiment score of 1.53 beat Edwards Lifesciences' score of 1.22 indicating that Abbott Laboratories is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Edwards Lifesciences	15 Very Positive mention(s)	3 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Abbott Laboratories	46 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Summary

Abbott Laboratories beats Edwards Lifesciences on 10 of the 17 factors compared between the two stocks.

How does Edwards Lifesciences compare to Intuitive Surgical?

Intuitive Surgical (NASDAQ:ISRG) and Edwards Lifesciences (NYSE:EW) are both large-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, institutional ownership, risk, dividends, media sentiment, valuation and earnings.

83.6% of Intuitive Surgical shares are held by institutional investors. Comparatively, 79.5% of Edwards Lifesciences shares are held by institutional investors. 0.6% of Intuitive Surgical shares are held by company insiders. Comparatively, 0.3% of Edwards Lifesciences shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

In the previous week, Intuitive Surgical had 43 more articles in the media than Edwards Lifesciences. MarketBeat recorded 65 mentions for Intuitive Surgical and 22 mentions for Edwards Lifesciences. Intuitive Surgical's average media sentiment score of 1.51 beat Edwards Lifesciences' score of 1.22 indicating that Intuitive Surgical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Intuitive Surgical	60 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Edwards Lifesciences	15 Very Positive mention(s)	3 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Intuitive Surgical has a beta of 1.46, meaning that its stock price is 46% more volatile than the broader market. Comparatively, Edwards Lifesciences has a beta of 0.87, meaning that its stock price is 13% less volatile than the broader market.

Intuitive Surgical has higher revenue and earnings than Edwards Lifesciences. Edwards Lifesciences is trading at a lower price-to-earnings ratio than Intuitive Surgical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Intuitive Surgical	$10.06B	14.31	$2.86B	$8.25	49.31
Edwards Lifesciences	$6.07B	8.30	$1.07B	$1.88	46.55

Intuitive Surgical has a net margin of 28.15% compared to Edwards Lifesciences' net margin of 17.39%. Intuitive Surgical's return on equity of 15.98% beat Edwards Lifesciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Intuitive Surgical	28.15%	15.98%	14.07%
Edwards Lifesciences	17.39%	15.19%	11.71%

Intuitive Surgical currently has a consensus price target of $573.42, suggesting a potential upside of 40.96%. Edwards Lifesciences has a consensus price target of $95.96, suggesting a potential upside of 9.66%. Given Intuitive Surgical's higher possible upside, equities analysts plainly believe Intuitive Surgical is more favorable than Edwards Lifesciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Intuitive Surgical	1 Sell rating(s)	7 Hold rating(s)	19 Buy rating(s)	0 Strong Buy rating(s)	2.67
Edwards Lifesciences	0 Sell rating(s)	8 Hold rating(s)	16 Buy rating(s)	3 Strong Buy rating(s)	2.81

Summary

Intuitive Surgical beats Edwards Lifesciences on 15 of the 17 factors compared between the two stocks.

How does Edwards Lifesciences compare to Stryker?

Edwards Lifesciences (NYSE:EW) and Stryker (NYSE:SYK) are both large-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, media sentiment, valuation, earnings, dividends, risk, analyst recommendations and institutional ownership.

Edwards Lifesciences has a net margin of 17.39% compared to Stryker's net margin of 13.20%. Stryker's return on equity of 23.42% beat Edwards Lifesciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Edwards Lifesciences	17.39%	15.19%	11.71%
Stryker	13.20%	23.42%	11.04%

Edwards Lifesciences presently has a consensus target price of $95.96, indicating a potential upside of 9.66%. Stryker has a consensus target price of $395.33, indicating a potential upside of 28.10%. Given Stryker's higher possible upside, analysts clearly believe Stryker is more favorable than Edwards Lifesciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Edwards Lifesciences	0 Sell rating(s)	8 Hold rating(s)	16 Buy rating(s)	3 Strong Buy rating(s)	2.81
Stryker	0 Sell rating(s)	6 Hold rating(s)	16 Buy rating(s)	0 Strong Buy rating(s)	2.73

In the previous week, Stryker had 13 more articles in the media than Edwards Lifesciences. MarketBeat recorded 35 mentions for Stryker and 22 mentions for Edwards Lifesciences. Stryker's average media sentiment score of 1.50 beat Edwards Lifesciences' score of 1.22 indicating that Stryker is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Edwards Lifesciences	15 Very Positive mention(s)	3 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Stryker	32 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Very Positive

79.5% of Edwards Lifesciences shares are held by institutional investors. Comparatively, 77.1% of Stryker shares are held by institutional investors. 0.3% of Edwards Lifesciences shares are held by insiders. Comparatively, 4.6% of Stryker shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Edwards Lifesciences has a beta of 0.87, suggesting that its stock price is 13% less volatile than the broader market. Comparatively, Stryker has a beta of 0.78, suggesting that its stock price is 22% less volatile than the broader market.

Stryker has higher revenue and earnings than Edwards Lifesciences. Stryker is trading at a lower price-to-earnings ratio than Edwards Lifesciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Edwards Lifesciences	$6.07B	8.30	$1.07B	$1.88	46.55
Stryker	$25.12B	4.71	$3.25B	$8.64	35.72

Summary

Edwards Lifesciences and Stryker tied by winning 8 of the 16 factors compared between the two stocks.

Get Edwards Lifesciences News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding EW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

EW vs. The Competition

Export

Metric	Edwards Lifesciences	MED INSTRUMENTS Industry	Medical Sector	NYSE Exchange
Market Cap	$50.30B	$7.11B	$6.43B	$23.21B
Dividend Yield	N/A	1.25%	2.68%	4.06%
P/E Ratio	46.55	39.10	20.90	28.67
Price / Sales	8.30	75.62	529.30	22.84
Price / Cash	30.64	25.66	27.92	18.67
Price / Book	4.91	7.26	10.81	4.69
Net Income	$1.07B	$159.20M	$3.57B	$1.08B
7 Day Performance	2.93%	-0.49%	0.72%	-0.82%
1 Month Performance	5.13%	1.29%	0.41%	1.07%
1 Year Performance	18.59%	7.51%	29.34%	25.02%

Edwards Lifesciences Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
EW Edwards Lifesciences	3.4466 of 5 stars	$87.51 +0.2%	$95.96 +9.7%	+18.6%	$50.30B	$6.07B	46.55	16,000	Positive News Analyst Forecast
HSIC Henry Schein	3.9007 of 5 stars	$81.09 -0.2%	$87.85 +8.3%	+11.0%	$9.26B	$13.18B	24.50	25,000	Positive News
AMN AMN Healthcare Services	1.7182 of 5 stars	$30.88 +0.2%	$25.29 -18.1%	+41.4%	$1.19B	$2.73B	N/A	2,664	News Coverage Analyst Upgrade Insider Trade Analyst Revision
ABT Abbott Laboratories	4.9902 of 5 stars	$88.76 +0.7%	$118.38 +33.4%	-33.4%	$153.59B	$44.33B	24.86	115,000	Positive News Dividend Announcement Analyst Downgrade
ISRG Intuitive Surgical	4.3139 of 5 stars	$416.55 +1.3%	$571.28 +37.1%	-20.1%	$145.58B	$10.06B	50.49	17,021	News Coverage Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:EW) was last updated on 6/21/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Edwards Lifesciences (EW) Competitors

EW vs. HSIC, AMN, ABT, ISRG, and SYK

How does Edwards Lifesciences compare to Henry Schein?

Summary

How does Edwards Lifesciences compare to AMN Healthcare Services?

Summary

How does Edwards Lifesciences compare to Abbott Laboratories?

Summary

How does Edwards Lifesciences compare to Intuitive Surgical?

Summary

How does Edwards Lifesciences compare to Stryker?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

EW vs. The Competition

Edwards Lifesciences Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Edwards Lifesciences (EW) Competitors

EW vs. HSIC, AMN, ABT, ISRG, and SYK

How does Edwards Lifesciences compare to Henry Schein?

Which has more risk and volatility, EW or HSIC?

Which has preferable earnings and valuation, EW or HSIC?

Does the media refer more to EW or HSIC?

Is EW or HSIC more profitable?

Do analysts prefer EW or HSIC?

Do insiders & institutionals hold more shares of EW or HSIC?

Summary

How does Edwards Lifesciences compare to AMN Healthcare Services?

Which has preferable valuation & earnings, AMN or EW?

Does the media prefer AMN or EW?

Is AMN or EW more profitable?

Do insiders & institutionals have more ownership in AMN or EW?

Which has more volatility and risk, AMN or EW?

Do analysts prefer AMN or EW?

Summary

How does Edwards Lifesciences compare to Abbott Laboratories?

Which has preferable earnings & valuation, EW or ABT?

Is EW or ABT more profitable?

Do analysts prefer EW or ABT?

Do institutionals & insiders hold more shares of EW or ABT?

Which has more risk and volatility, EW or ABT?

Does the media refer more to EW or ABT?

Summary

How does Edwards Lifesciences compare to Intuitive Surgical?

Do institutionals and insiders have more ownership in ISRG or EW?

Does the media prefer ISRG or EW?

Which has more volatility and risk, ISRG or EW?

Which has preferable earnings and valuation, ISRG or EW?

Is ISRG or EW more profitable?

Do analysts rate ISRG or EW?

Summary

How does Edwards Lifesciences compare to Stryker?

Is EW or SYK more profitable?

Do analysts prefer EW or SYK?

Does the media favor EW or SYK?

Do institutionals & insiders believe in EW or SYK?

Which has more risk and volatility, EW or SYK?

Which has better earnings & valuation, EW or SYK?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

EW vs. The Competition

Edwards Lifesciences Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools